Medtronic CFO Karen Parkhill jumps ship to HP
Adds Medtronic forecast in paragraph 8, updates share movement
June 26 (Reuters) - Medical device maker Medtronic'sMDT.N finance chief Karen Parkhill will depart the medical device maker to join HP Inc HPQ.N as CFO, the companies said on Wednesday, amid the PC industry's recovery from its extended post-pandemic slump.
Parkhill, who spent the last eight years as CFO at Medtronic, will join HP on Aug. 5 and succeed Marie Myers, who left the personal computer maker for server maker Hewlett Packard Enterprise HPE.N.
Parkhill has previously served as CFO for commercial banking at JPMorgan Chase and Co<JPM.N>and has held several other leadership roles.
Her appointment comes at a pivotal time for the industry, with companies like HP Inc. and Dell betting on AI PCs to drive recovery after a years-long post-pandemic slump.
In an interview last month, HP CEO Enrique Lores told Reuters that he expected about 10% of HP's PC sales to come from such "AI PCs" in the second half of the company's fiscal 2024.
Parkhill's exit comes months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI) business.
"The key question for investors is whether Karen’s decision to move to another company that is having growth challenges is signaling anything," Evercore ISI analyst Vijay Kumar said.
Medtronic reiterated its full-year financial forecast for fiscal year 2025 after Parkhill's departure.
Gary Corona, senior vice president of global financial planning and analysis, will serve as interim finance chief of the medical device maker upon Parkhill's departure.
Medtronic's shares were down 1% in noon trading. They have fallen roughly 9% in the past 12 months.
Reporting by Sneha S K and Manas Mishra in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
